The rat tumour lines were included because the rat, different from the human C4.4A-specific antibodies, has been shown to recognize C4.4A indendently of gylcosylation and, in addition, is well suited for immunoprecipitation (Matzku et al, 1989; Rösel et al, 1998). The gene discussed is LYPD3; the disease is neoplasm.